Cefotaxime is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Wockhardt Usa Llc.. The primary component is Cefotaxime Sodium.
Product ID | 64679-947_4d51bfa3-dadf-44bc-a2b6-75f477945341 |
NDC | 64679-947 |
Product Type | Human Prescription Drug |
Proprietary Name | Cefotaxime |
Generic Name | Cefotaxime |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2008-06-20 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA065197 |
Labeler Name | Wockhardt USA LLC. |
Substance Name | CEFOTAXIME SODIUM |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2008-06-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA065197 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-06-20 |
Marketing Category | ANDA |
Application Number | ANDA065197 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-06-20 |
Ingredient | Strength |
---|---|
CEFOTAXIME SODIUM | 500 mg/1 |
SPL SET ID: | f3c5895f-f54b-43d4-9b38-7bfbdf8335b7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0143-9930 | Cefotaxime | Cefotaxime |
0143-9931 | Cefotaxime | Cefotaxime |
0143-9933 | Cefotaxime | Cefotaxime |
0143-9935 | Cefotaxime | Cefotaxime |
21586-011 | Cefotaxime | cefotaxime injection |
21586-012 | Cefotaxime | cefotaxime injection |
55648-947 | CEFOTAXIME | CEFOTAXIME |
55648-948 | CEFOTAXIME | CEFOTAXIME |
55648-986 | CEFOTAXIME | CEFOTAXIME |
64679-947 | Cefotaxime | Cefotaxime |
64679-948 | Cefotaxime | Cefotaxime |
64679-986 | Cefotaxime | Cefotaxime |
68180-811 | CEFOTAXIME | CEFOTAXIME |
68180-822 | CEFOTAXIME | CEFOTAXIME |
68180-833 | CEFOTAXIME | CEFOTAXIME |